Medical research has historically had an issue with studying broad enough populations. In the beginning, it was often either White men or people in situations where they were unaware or without freedom to choose. HIV research may not have been done by force or duplicity, but it has been historically just as limited.
Early on, most the studies were only on White males. Then slowly they began adding people of color. Then they added trans-women. But seldom were woman or girls included in the research. If they were, it was generally much later in development.
This article is about Gilead's attempt to design inclusive studies. In sub-Saharan Africa, woman are more greatly impacted by HIV. Any research there should focus foremost on them. The piece goes into more detail about how they have used this during their research for their long acting injectable.
Give this a read. Hope everyone is doing well. We're trying to do as well as we can.
Take care.
Cya...
No comments:
Post a Comment